Markets
Stocks
Funds
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Recent Quotes
My Watchlist
Indicators
Acadia Pharmaceutica (NQ: ACAD)
46.26 USD  -1.67 (-3.48%)
Streaming Delayed Price  /  Updated: 6:49 PM EST, Dec 10, 2019  /  Add to My Watchlist      
View: Quote News Research
Price and Volume
Detailed Quote
Chart for (: )
 
Intraday
1 Week
1 Month
3 Month
1 Year
  
Compare to:
Volume 1,840,437
Open 47.89
Bid (Size) 46.26 (1)
Ask (Size) 46.99 (2)
Prev. Close 47.93
Today's Range 46.05 - 48.75
52wk Range 14.01 - 53.70
Shares Outstanding 124,825,969
Dividend Yield N/A
Performance
YTD
+177.84%
+177.84%
1 Month
+2.25%
+2.25%
3 Month
+19.07%
+19.07%
6 Month
+80.28%
+80.28%
1 Year
+146.33%
+146.33%
Top News
More News
ACADIA Pharmaceuticals Presents Positive Top-line Results from Pivotal Phase 3 HARMONY Trial of Pimavanserin in Patients with Dementia-Related Psychosis at 12th Clinical Trials on Alzheimer’s Disease
ACADIA Pharmaceuticals Inc. (Nasdaq: ACAD) today presented positive top-line results from its Phase 3 HARMONY study at the 12th Clinical Trials on Alzheimer’s Disease (CTAD) Meeting, December 4 -7,... Read More
from Business Wire News Releases
Notable Thursday Option Activity: ITCI, ALLK, ACAD
Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Intra-Cellular Therapies Inc (ITCI), where a total volume of 11,658 contracts has... Read More
category Stocks
from Market News Video
More News
Read More
Save Yourself the Migraine and Buy This 1 Pharma Stock Now
category Market News , SAGE , TEVA , and 6 more.
from Motley Fool
Stocks Stall On December 5, Ahead Of The Employment Report
category Stocks / Equities
from Blogs - TalkMarkets
Why This Highflying Biotech Stock Zoomed Near A Profit-Taking Zone
from Investor's Business Daily
Acadia Pharma's psychosis drug proven better than placebo in dementia patients
category companyNews
from Reuters: Company News
Why Acadia Pharmaceuticals Stock Is on Fire Today
category ACAD , Market News
from Motley Fool
Interesting ACAD Put And Call Options For January 2020
category Stocks
from Market News Video
Acadia Pharmaceu Shares Up 16.6% Since SmarTrend's Buy Recommendation (ACAD)
from Comtex SmarTrend® News Briefs
Patrick Healey On Why A Mini-Correction Would Be Healthy
from Investor's Business Daily
Stocks Are Pointing To More Gains For November 27
category Stocks / Equities
from Blogs - TalkMarkets
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Six Financial & Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.